Polarean Imaging Plc (GB:POLX) has released an update.
Polarean Imaging plc has announced a significant milestone with the University of Alabama at Birmingham Hospital’s de novo order of its innovative Xenon MRI System, marking the technology’s first-time acquisition in the southeastern U.S. and illustrating the growing impact of Polarean’s MRI solutions. The installation of this system is slated for later this year and is expected to support clinical imaging, NIH-funded research, and pharmaceutical trials. Polarean’s growth strategy seems to be paying off, with current sales and firm orders set to yield a revenue of approximately $2.5M for 2024, and additional orders likely to increase this figure.
For further insights into GB:POLX stock, check out TipRanks’ Stock Analysis page.
